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ABSTRACT 
 
A change in paradigm is needed in the prevention of toxic effects on the nervous 
system,  moving from its the present reliance solely on data from animal testing to a 
prediction model mostly based on in vitro toxicity testing and in silico modelling. 
According to the report published by the National Research Council (NRC) of the US 
National Academies of Science, high-throughput in vitro tests will provide evidence for 
alterations in "toxicity pathways" as the best possible method of large scale toxicity 
prediction. The challenges to implement this proposal are enormous, and provide much 
room for debate. While many efforts address the technical aspects of implementing the 
vision, many questions around it need also to be addressed. Is the overall strategy the 
only one to be pursued? How can we move from current to future paradigms? Will we 
ever be able to reliably model for chronic and developmental neurotoxicity in vitro?.  
This paper summarizes four presentations from a symposium held at the International 
Neurotoxicology Conference held in Xi’an, China, in June 2011. A. Li reviewed the 
current guidelines for neurotoxicity and developmental neurotoxicity testing, and 
discussed the major challenges existing to realize the NCR vision for toxicity testing.  J. 
Llorens reviewed the biology of mammalian toxic avoidance in view of present 
knowledge on the physiology and molecular biology of the chemical senses, taste and 
smell. This background information supports the hypothesis that relating in vivo toxicity 
to chemical epitope descriptors that mimic the chemical encoding performed by the 
olfactory system may provide a way to the long term future of complete in silico toxicity 
prediction. S. Ceccatelli reviewed the implementation of rodent and human neural stem 
cells (NSCs) as models for in vitro toxicity testing that measures parameters such as 
cell proliferation, differentiation and migration. These appear to be sensitive endpoints 
that can identify substances with developmental neurotoxic potential. C. Suñol 
reviewed the use of primary neuronal cultures in testing for neurotoxicity of 
environmental pollutants, including the study of the effects of persistent exposures 
and/or in differentiating cells, which allow recording of effects that can be extrapolated 
to human developmental neurotoxicity.  
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Introduction. 
The founder of modern toxicology, Mateu Orfila (1787 - 1853), recognized that 
toxic effects on the nervous system include extreme diversities of both causes and 
outcomes (Orfila, 1826). The extreme diversity of cell types and cell interactions 
included in the nervous system, and the associated selectivity that most toxic actions 
show for a single or a limited number of these kinds of cells (Spencer, 2000) make 
predicting toxicity in this system a challenging task within the view proposed by the 
report “Toxicity testing in the 21st century: A vision and a strategy” (NRC, 2007). This 
report advocates for a toxicity testing strategy that relies on high throughput in vitro 
tests sensitive to key effects on “toxicity pathways”. In the era of molecular cell biology, 
robotics and informatics, this proposal seems a good one, but whether or not it will 
really answer the needs is an open question. Many meetings and symposia have 
focused on the results obtained in the development of methods for high throughput 
testing. However, there is also a need for debating the overall strategy, and for 
evaluating fundamental aspects of neurotoxicity studies that are relevant to the value of 
the testing schemas. 
This article summarizes a symposium entitled Strategies and tools for 
preventing neurotoxicity: to test, to predict and how to do it that was presented at the 
Xi’an International Neurotoxicology Conference, Neurotoxicity and Neurodegeneration: 
Local Effect and Global Impact held on June 5-10, in Xi’an, China. The first speaker in 
this symposium, Dr. Abby Li, reviewed the current test guidelines for adult and 
developmental neurotoxicity testing, and extended on the needs and challenges 
involved in the transition from the present scenario to the one envisaged by the NRC 
21st century vision report. The second speaker, Dr. Jordi Llorens, defended the 
hypothesis that we may go beyond the NRC 21st century proposal and also start 
preparing for a long term goal of a complete in silico neurotoxicity prediction. He 
reviewed the role of the taste and olfactory systems in toxic avoidance by living 
mammals to conclude that a great effort in in vivo toxicity studies is also necessary to 
collect a database of toxic effects related to chemical epitopes, on which the in silico 
modeling can be based. The two remaining talks reviewed the results from the author’s 
own laboratories that are of highly relevance for future developments of in vitro testing 
strategies. One major challenge to these strategies is the need to evaluate the potential 
of chemicals for chronic neurotoxicity and neurodevelopmental toxicity. Dr. Sandra 
Ceccatelli reported on her studies using neuronal stem cells for in vitro neurotoxicity 
evaluation, as chemicals with preferential activity against these cells are likely to be 
neurodevelopmental toxicants. She showed how the phenomena of cell proliferation, 
differentiation and migration can be studied in these cells, and the impact of neurotoxic 
exposure on these parameters that are well recognized as critical points in 
neurodevelopment. The fourth speaker, Dr. Cristina Suñol, reviewed her results using 
neuronal cell cultures exposed to environmental pollutants for several days. Her results 
indicate that neuronal in vitro systems can be used not only to evaluate cytotoxic 
effects, but also to assess more subtle effects such as the establishment of persistent 
changes in synaptic transmission, more likely to be relevant for chronic neurotoxicity 
and neurodevelopmental toxicity. Together, the symposium contributed to the debate 
about how we will predict neurotoxicity and neurodevelopmental toxicity in the future. 
 
 
Regulatory Neurotoxicity Testing for Risk Assessment Purposes:  Current and 
Future Approaches. 
Abby A. Li, Ph.D. Exponent Health Sciences, San Francisco, USA 
 
 Current test guidelines for standard toxicity testing, acute and subchronic 
neurotoxicity testing, and developmental neurotoxicity (DNT)  testing rely primarily on 
behavioral and histopathology evaluations of the nervous system (Tables 1 and 2). For 
example, the DNT test requires an evaluation of different types of behavioral measures 
including gross neurologic and behavioral abnormalities, motor activity, startle 
habituation and neuropathologic evaluations including morphometric measures (Table 
2).  This test is designed to assess different types of behavioral functions and evaluate 
histopathology sections throughout the central and peripheral nervous system. The 
study designs require three treatment groups and one control group with the highest 
dose level inducing systemic toxicity, but not death or severe suffering of the animals.  
EPA’s Neurotoxicity Risk Assessment Guidelines (USEPA, 1998) and OECD’s 
guidance document on neurotoxicity testing (OECD, 2004) provide guidance on 
interpreting functional and morphologic changes.  Specifically, changes in behavior 
may be adverse but are not necessarily the result of a direct effect on the nervous 
system, especially when testing chemicals near the maximum tolerated dose (USEPA, 
1998).  In addition, evaluation of whether behavioral changes are adverse should take 
into consideration the consistency of the pattern of effects.  For example, in evaluating 
results from the functional observational battery (FOB), which can include more than 30 
different measures of normal and/or abnormal behaviors, “the risk assessor should be 
aware of the potential for a number of false positive statistical findings in these studies 
because of the large number of endpoints customarily included in the FOB” (USEPA, 
1998).  OECD (2004) and USEPA (1998) recommend that the assessment of 
neurotoxicity should incorporate a level of concern based on the type, severity, 
number, and either full or partial reversibility of the effect(s).  A pattern or cluster of 
related effects generally causes a higher level of concern than individual or unrelated 
effects.  However, the observation of some specific endpoints, even those of limited 
duration in time (e.g., body tremors, convulsions) may be sufficiently important 
depending on dose level and relative sensitivity compared to other toxicity endpoints 
(OECD, 2004). 
 Different regulatory agencies have different testing requirements for 
neurotoxicity testing depending on chemical class, use, volume of production, or extent 
of exposure to humans.  The USEPA Office of Pesticide Programs (USEPA OPP) 
requires acute and subchronic neurotoxicity testing in adults for all food use pesticides 
(USEPA, 2011).  USEPA OPP considers the developmental neurotoxicity test (DNT) as 
conditionally required based on evidence of (1) treatment-related neurological effects in 
adult or developing animals, (2) a causative association between exposures and 
adverse neurological effects in human epidemiological studies, or (3) a mechanism of 
action that is associated with adverse effects on the development of the nervous 
system (e.g., structure activity relationship to known neurotoxicants, altered 
neuroreceptor or neurotransmitter responses) (USEPA, 2011). 
 For other regulatory agencies and types of chemicals, the first animal data 
indicating a need for neurotoxicity assessment are provided by standard toxicity studies 
where functional and/or histopathological information is gathered on all major organ 
systems, including the nervous system (Table 2; OECD, 2004).  When there are 
indications of possible neurotoxic effects, additional endpoints may be included in the 
initial standard tests(s), or the results may trigger the need for adult and/or 
developmental neurotoxicity tests (OECD, 2004).  
 A tiered approach to testing is consistent with the report titled Toxicity Testing in 
the 21st Century (NRC, 2007, p.28), which concluded that the intensity and depth of 
testing should focus resources on the evaluation of the more sensitive adverse effects 
of exposures of greatest concern rather than on full characterization of all adverse 
effects irrespective of relevance for risk-assessment and risk-management needs. It 
also stated that testing strategies need to balance the depth and breadth of testing with 
animal welfare concerns and expenditure of money and time on testing and regulatory 
review.  This tiered testing approach depends on a first tier of testing that adequately 
and rapidly screens for a large number of chemicals for all endpoints of importance 
including neurotoxicity in adult and developing animals.  
 Current test methods for neurotoxicity testing, especially DNT, are resource 
intensive and use a large numbers of animals (at least 900 animals for DNT studies).  
Draft OECD guidelines for an extended 1-generation study include DNT endpoints as a 
means of combining elements of DNT testing with a reproduction study (OECD, 2010, 
Table 2).  In addition, some of the behavioral endpoints may have high inherent or 
experimental variability (Raffaele et al., 2008).  This variability is a result, in part, to the 
fact that 20–40 pups/litter/dose level must be tested at specific ages over a span of 4–5 
days depending on when the pups from all litters are born. These studies could be 
conducted using staggered start dates for different replicates, but extending testing 
across weeks or months can contribute further to variability of the data.  Thus, 
approaches that might improve screening of potential neurotoxicants could aid in 
prioritizing chemicals for further neurotoxicity testing. 
 The new NRC 21st century vision emphasizes the use of high-throughput 
assays, computational tools, and scientific advances in understanding perturbations of 
cellular-response networks—complex interaction of genes, proteins, and small 
molecules—that lead to adverse health effects (Judson et al., 2010; Martin et al., 2011; 
NRC, 2007).  Other approaches include the use of a battery of medium-throughput in 
vitro cell culture assays to model key events of brain development such as proliferation, 
differentiation, migration, neurite growth, synaptogenesis, myelination, and apoptosis. 
Additionally, alternative nonmammalian species (e.g., zebrafish, C. elegans) can be 
used to screen for chemical effects on an intact rapidly developing nervous system 
(Coecke et al., 2007; Lein et al., 2005, 2007; MacPhail et al., 2009; Radio and Mundy, 
2008; Ton et al. 2006).    
 There are significant challenges in realizing this vision for toxicity testing.  
These include (1) identifying and validating batteries of tests, (2) separating adaptive or 
negligible perturbations from those that are adverse, (3) determining if all sensitive 
windows of development are adequately tested, and (4) understanding the relevance of 
dose-response relationships in in vitro systems to human exposures (NRC, 2007). As a 
first step towards identifying and comparing different batteries of in vitro tests for 
purposes of screening chemicals for prioritization, Crofton et al. (2011) developed a set 
of best practices or principles to facilitate comparison of new approaches across 
different laboratories.  These general principles still need to be translated into specific 
criteria.  At present, comparisons across laboratories are hampered by use of different 
testing conditions in different laboratories; use of too few (e.g., <5) or different positive 
and negative controls for specific endpoints; limited comparisons between endpoints 
measured and reliable measures of cytotoxicity; too few doses (e.g., <10) or insufficient 
number of replicates (e.g., <3); and inadequate reporting of test material purity, testing 
conditions, and results.  Protocol optimization and standardization are essential first 
steps that are required before methods can be validated for use in a regulatory testing 
scheme (Crofton et al., 2011). In addition, specific criteria based on these general 
principles outlined by Crofton et al. (2011) should be inclusion criteria for any 
exploratory data-mining computational efforts.  At present, it is premature to make any 
conclusions about which battery of in vitro methods, if any, will improve developmental 
neurotoxicity testing.      
 An integral part of the NRC 21st century vision that has not been given sufficient 
attention is the use of targeted testing to complement toxicity pathway tests and to 
support toxicity evaluation for risk assessment purposes.  Targeted in vivo or in vitro 
testing can be used to investigate and clarify uncertainties with mechanisms, 
metabolites, target tissue reactions, and cellular responses at the genomic level (NRC, 
2007).  These could involve limited types and shorter duration in vivo studies. For 
instance, existing toxicity-test systems using standard animals, as well as transgenic 
species, could include toxicogenomic endpoints that are considered reliable early 
predictors of toxicity.  Plunkett et al. (2010) proposed a flexible integrated approach 
that targets testing based on physiochemical properties, knowledge of potential mode 
of action of the specific or related chemicals, biological profiling using in silico methods, 
and information of potential exposures.  Such an approach, if focused on the most 
sensitive endpoints based on dose-response comparisons, is consistent with the NRC 
21st century vision and provides an evolutionary path forward to gradually adopt new 
methods.   
 Integrated testing approaches that use current and new approaches for 
neurotoxicity testing have the potential of reducing the number of redundant animal 
tests, while increasing the breadth of testing associated with those animal tests.  
Although significant challenges lie ahead for validation of new approaches and 
interpretation of the results, new technologies have the potential of assessing 
endpoints that are more specific to the developing nervous system, including obligatory 
“precursor” events that are predictive of neurologic diseases that are difficult to screen 
using behavioral tests in animal models (e.g., ADHD, autism).  In addition, medium or 
high throughput methods have the potential to improve the grouping of chemicals by 
similar mode of action instead of relying exclusively on chemical structure. This can 
reduce animal testing by providing scientific basis for selecting a representative 
chemical to be tested for a group of chemicals with similar mode of action.  Finally, if 
properly validated, these approaches will improve screening of chemicals for potential 
neurotoxicity and focus additional testing resources towards those chemicals of 
greatest concern.  
 
 
 
Toward Neurotoxicity Testing in the 22nd Century: A Vision, a Taste or a Smell? 
Jordi Llorens. Department of Physiological Sciences II, Universitat de Barcelona – 
IDIBELL, Hospitalet de Llobregat, Spain 
 
 
Traditional methods for neurotoxicity prediction and prevention have been 
based on animal testing. Now, the substitution of animal testing for in vitro testing is on 
the table for debate, but there is no much debate on the need for testing. And what we 
really need at the end is to prevent neurotoxic damage by predicting it; testing is only a 
means of obtaining data useful for prediction. So why not postulate that the ultimate 
long term goal, the one for the 22nd century, should be to have the capacity to fully 
predict toxicity in silico?. If we aim at this long-term goal, one relevant question is 
whether current efforts for developing high throughput testing system are also in the 
right direction for this objective, or we need to devote additional efforts in other 
directions. This part of the symposium discussed the strategy used by mammals for 
toxicity avoidance, with the purpose of learning about a quite successful strategy from 
which some useful ideas may emerge. No long ago, we prevented toxicity as wild 
mammals using our sensory systems to avoid ingestion of toxic foods. Many factors 
now make this biological system for (neuro)toxicity prevention an insufficient one. 
These include 1) dermal and inhalation routes of exposure are increasingly significant 
in contrast to the oral route that likely predominated toxic exposure during evolution; 2) 
high concentrations of lipophilic compounds are likely more abundant in our present 
environment than in common foods of the pre-Neolithic times; 3) toxic molecules may 
belong to new classes of compounds, differing from anything we have encountered 
previously during evolution; 4) increased life expectancy makes the long term, delayed 
or cumulative effects much more important. This is an aspect in which the nervous 
system emerges as the main one of concern because of its limited capacity for 
regeneration. These factors make it important that toxicological sciences help us to 
prevent toxic damage, but they do not invalidate the logic behind the biological 
strategy, which has been quite successful. Modern biological sciences provide an 
overall understanding of some major features of sensory physiology, and we can 
hypothesize how they act in toxicity prevention and perhaps learn some useful lessons. 
Chemical components included in food are analyzed by two major sensory 
systems, the taste system in the oral cavity and the olfactory system by the retronasal 
route. In the taste system, each taste cell selectively responds to one of a few basic 
taste modalities (for a review, see Chandrashekar et al., 2006), five of which are 
currently recognized: salty, sour, bitter, sweet and umami. Some other basic tastes 
may exist, as one for lipids, but the list is quite short in any case. The bitter taste is the 
one that specializes in detecting toxic compounds to be avoided, although extremely 
salty and sour tastes also generate avoidance responses. Bitter compounds are those 
that bind to bitter taste receptors, a family of around thirty G-protein coupled receptors 
known as T2Rs (for taste-2 receptors) (Adler et al., 2000). All of these bitter receptors 
are expressed in the same taste cells, which act as broadly tuned bitter sensors that 
are wired to mediate behavioral aversion and differ from the ones mediating the other 
taste modalities (Mueller et al, 2005). This organization has some important 
implications.  
First, there is one single bitter perception, we can discriminate among different 
concentrations of bitter compounds, but we cannot distinguish among different classes 
of bitter compounds. Second, our ability to detect toxic compounds by their taste 
depends on genetic information encoded in the bitter receptors. Third, the bitter 
receptors are likely adjusted to bind compounds with a relevant toxic role during our 
evolutionary history. Fourth, the small number of existing T2Rs, 25 in humans, implies 
that, even if broadly tuned, only a few hundred bitter compounds are probably 
detectable. Thus, the bitter taste system seems adapted to provide a fast warning 
signal for bulk content of toxins in food, but with no discrimination ability (Yarmolinsky 
et al., 2009). 
In contrast to the few modalities existing for taste perception, there are no basic 
modalities for olfactory perception. There are hundreds of different olfactory receptors 
(339 in humans, 913 in mice) and each of them is expressed in a specific population of 
olfactory neurons that will respond to chemicals binding to this particular receptor (Buck 
and Axel, 1991; Uchida et al., 2000; reviewed by DeMaria and Ngai, 2010). Each 
olfactory receptor (and therefore each class of olfactory neuron) is activated by 
compounds with certain molecular features (e.g., aldehydes), but is also broadly tuned 
for other characteristics (e.g. carbon chain length). The receptor does not recognize the 
entire molecule, but a part of it, a “chemical epitope”, and will be activated by different 
molecules that have this epitope in common. Overall, the olfactory system uses several 
hundreds of receptors for chemical recognition to respond to an endless list of 
molecules, each encoded as a particular combination of chemical epitopes; it is a 
system for detailed chemical analysis with a very high capacity for discrimination. This 
capacity for discrimination can be used for toxic avoidance following rules that are 
learned. It is well known that mammals develop robust avoidance responses to flavors 
once paired with sickness (Garcia et al., 1955). Current knowledge on the physiology of 
the taste and smell systems indicates that the olfactory system must be the main one 
involved in the chemical recognition necessary for this response. 
The mammalian system for avoiding toxicity is thus based in two 
complementary strategies. First, the taste system is used to avoid ingestion of toxic 
doses of potentially harmful compounds as genetically encoded in the bitter receptors. 
Second, foods and drinks accepted by the taste system are submitted to a detailed 
chemical analysis and refused in the future if signals of disease (pain, nausea, 
dizziness) follow the previous ingestions. 
The proposed strategy for toxicity testing based on high throughput in vitro tests 
sensitive to key effects on toxicity pathways will, if successful, provide a system that 
will share many features with the taste system. Test validation will take place of 
evolutionary selection, and the process will likely provide a limited number of test 
systems for high throughput toxicity testing, as we have a limited number of bitter taste 
receptors for quick rejection of toxic compounds. These systems will have limitations 
imposed by the currently available knowledge in the same way that bitter receptors 
likely recognize only toxic compounds that we have encountered in significant amounts 
during evolution. So we will need a second system that, like the avoidance learning 
system based on olfactory information, is open to learning about new toxic effects 
caused by new compounds that have passed the first screen. The advantage now is 
that any new knowledge will persist and not disappear, in the way that flavor aversions 
are lost when the subject dies. 
Our system open to learning will necessarily cover some gaps in the biological 
system, including associations for chronic and delayed toxicity, but other parts can be 
mimicked. In particular, the “chemical epitope” approach of describing the chemical 
world used by the olfactory system is likely to be useful in terms of toxicity prediction, 
and is likely to be particularly well suited for in silico modeling. Because a few hundreds 
of olfactory receptors exist, perhaps a similar or a few times greater number of epitope 
descriptor models (from 300 to 3,000 in total) could be enough (that is, any chemical 
potentially interacting with our organism could be satisfactorily described as a 
combination of several of these possible epitopes). Recent improvements in chemical 
description for quantitative structure-activity relationship (QSAR) methods, as group-
based QSAR (Ajmani et al., 2009) appear to be moving in the direction of a closer 
resemblance to the chemical epitope recognition performed by the olfactory system. 
Besides chemical description, the system will need toxicity data for pairing 
chemical epitopes with the toxicity outcomes. In my opinion, because they include the 
largest possible variety of initial targets and integrate all the necessary parameters 
involved in toxicity outcome, in vivo studies, using multiple species and paradigms, are 
likely to be the most efficient way to generate the needed knowledge, whatever the 
toxicity pathways linking the initial targets to the final toxic effect. Although we know 
about the many kinetic and dynamic variables involved in any toxic effect, it is 
compelling to recognize that the natural avoidance system simply pairs olfactory 
chemical analysis with a few apical indices of illness. Also, the nervous system may 
include many unique toxicity pathways, but its singularity for toxicity more likely relies 
on the diversity of initial targets it contains.   
The above information leads me to express two proposals. The first major 
proposal is that in addition to developing tests for high throughput toxicity testing we 
need to make a huge effort of data collection, including much in vivo data, to approach 
the dreamed end goal of in silico toxicity prediction. In vivo testing represents the 
evaluation of an unbeatable diversity of potential targets that we need to take into 
account in our efforts to toxicity prediction. It is obvious that we cannot test all 
chemicals in live mammals, but there is a lot that we need to learn from in vivo models, 
including mammalian species. A relevant effort generating useful data is that of the 
pharmaceutical industry in both pre-clinical tests and clinical trials; how we get to use 
this information is a relevant question. Although pharmaceuticals are intentionally 
designed to minimize their toxicity and are thus a biased sample of the chemical 
universe, the discovery of unexpected toxic effects associated with new chemical 
epitopes may provide useful cues for subsequent in silico toxicity prediction. 
Importantly, if toxic effects are found at the clinical trial level, after extensive pre-clinical 
testing, this indicates human-specific effects.          
A second proposal is that we may want to use the chemical epitope logics for 
data collection and analysis. In most cases, toxicity evaluation is driven by chemical 
use and its known toxicity. That is, toxicity studies focus on compounds that we are 
significantly exposed to or that are identified as potentially toxic at dose levels similar to 
exposure levels. This seems a sound way of using the available resources. However, I 
propose that we also need to devote a significant amount of resources to evaluate 
toxicity for families of chemicals defined by a particular chemical epitope, as this may 
generate knowledge particularly useful for the final goal of in silico prediction. One 
example of the potential interest of this approach is the work by LoPachin et al. (2008) 
raising the hypothesis that conjugated ,-unsaturated carbonyl derivatives (that is, 
chemicals containing this particular chemical epitope) are particularly prone to cause 
neurotoxicity by presynaptic damage via protein adduct formation. Another example is 
the study on the neurotoxic effects of nitriles (compounds with a cyano, R-CN, group) 
on the sensory and central nervous systems. Many nitriles are known to cause acute 
toxicity through cyanide release by xenobiotic metabolism enzymes, a toxic endpoint 
already addressed by some modeling studies (Grogan et al., 1992). The work by 
several groups, including ours, has demonstrated that several nitriles cause a variety of 
neurotoxic effects, such as degeneration of specific populations of neurons in the 
central nervous system (Boadas-Vaello et al., 2005; Seoane et al., 2005) and 
degeneration of sensory systems including the olfactory (Genter et al., 1992), auditory 
(Gagnaire et al., 2001) and vestibular systems (Llorens et al., 1993; Balbuena and 
Llorens, 2001, 2003). We have observed that vestibular toxicity is not related to 
cyanide release (Boadas-Vaello et al., 2007, 2009) and is associated with strict 
structural requirements (Balbuena and Llorens, 2003) that may depend on the animal 
species, as the case of trans-crotononitrile, which causes neuronal degeneration in the 
rat (Boadas-Vaello et al., 2005; Seoane et al., 2005) and vestibular toxicity in the 
mouse (Saldaña-Ruíz et al., 2012). An evaluation of 19 similar nitriles for vestibular 
toxicity in the mouse has resulted in 5 positive nitriles (Saldaña-Ruíz et al., 2012). We 
hypothesize that the nitrile group has a diverse but limited number of neurotoxic 
effects, and that the structural motifs leading to each one of them will be amenable to 
modeling. That is, we will probably be able to define a small number of chemical 
epitopes containing the nitrile group and causing different neurotoxic effects, and to 
model the relationship between chemical structure and neurotoxicity for all of them. As 
these relationships most often depend on chemical-to-protein interaction, species-
specific differences emerge, but these will be included in the models.   
Similarly to the above examples, any given group or chemical epitope may have 
a diverse but probably limited number of toxic effects. Detection and characterization of 
all these effects for future modeling and prediction looks like an enormous task. To 
begin with, one would like to have an estimate of its size, as imprecise as it may be.   
My hypothesis is that the numbers provided by the olfactory system, from several 
hundreds to a few housand epitopes, provide such a rough estimate and it does not 
look impossible in a century perspective.  
 
 
Neurotoxicity Testing: The Challenge Of In Vitro Alternatives  
Sandra Ceccatelli. Department of Neuroscience, Karolinska Institutet, Stockholm, 
Sweden 
 
The complex anatomical and physiological organization of the nervous system, 
with different cell types forming networks essential to maintain all integrated functions, 
cannot be reproduced in in vitro systems.  However, the use of multiple in vitro models, 
including primary cultures of neurons obtained from specific brain areas, cell lines of 
different origin, co-culture systems with neuronal and glial cells, have been shown to be 
valuable in neurotoxicological research.  The nervous system is particularly sensitive to 
alterations of the microenvironment occurring during development, and there is growing 
evidence pointing to developmental exposure to chemicals as possible cause of 
nervous system disorders (Landrigan et al., 2005). Well characterized in vitro model 
systems are therefore needed for large scale “animal-free” screening of chemicals and 
pharmaceutical drugs for the assessment of neurotoxic effects, with special focus on 
developmental neurotoxicity (DNT). 
In recent years, we have successfully implemented the use of neural stem cells 
(NSCs) as models for in vitro DNT tests (Sleeper et al., 2002; Tamm et al., 2004, 2006, 
2008a,b,c).  NSCs play a critical role in the developing embryonic nervous system 
through to adulthood, where the ability for self-renewal appears to be important for 
normal functions, such as learning, memory, and response to injuries. Using NSCs 
from rodents and humans, we have investigated the effects of environmental 
contaminants, such as methylmercury (MeHg) and non-dioxin-like polychlorinated 
biphenyls (PCBs) on survival and differentiation potential. 
We prepare primary cultures of NSCs from embryonic cortices from timed-
pregnant Sprague–Dawley rats (Harlan Laboratories, The Netherlands) at E15 (the day 
of copulatory plug was defined as E0).  Primary embryonic/fetal human neural cells, 
derived from fetuses terminated at gestational week (GW) 6 -16, are cultured as 
neurospheres or dissociated cells. To study proliferation and survival, cells are 
maintained in a medium enriched with appropriate growth factors to keep cells in an 
undifferentiated and proliferative state. Studies on spontaneous differentiation and 
migration capabilities are performed in the absence of growth factors 
Briefly, our results show that NSCs are highly sensitive to neurotoxicants, as 
compared to other neural cell types (Tofighi et al. 2011a). MeHg induces apoptosis via 
Bax-activation, cytochrome c translocation and caspases, as well as calpain activation. 
Conversely, the selected PCBs tested (PCB 153 and 180) induce cell death via a 
lysosome-dependent pathway. Remarkably, developmental exposure to MeHg, at 
concentrations comparable to those found in the cord blood of the general population in 
many countries, inhibits spontaneous neuronal differentiation of NSCs via Notch 
signaling (Tamm et al. 2006; 2008a).  On the contrary, nanomolar concentrations of 
PCB 180 and 153 increased spontaneous neuronal differentiation, as shown by the 
increase in Tuj1 positive cells, with a concomitant decrease in proliferating cells, as 
detected by EdU-staining. Combined exposures to PCBs and MeHg resulted in a 
synergistic interaction with regard to the induction of apoptotic cell death and an 
antagonistic interaction on spontaneous neuronal differentiation of NSCs (Tofighi et al. 
2011b). 
With regard to human NSCs, after several tests, we came to the conclusion that 
for proliferation or differentiation assays, dissociated cells provide the most reliable 
results. For migration assays instead, we implemented intact neurospheres. Cells from 
different developmental stages cultured as neurospheres were exposed to a range of 
MeHg concentrations (2.5nM, 10nM, 25nM, 100nM) and alterations in differentiation 
and migration were examined and compared to untreated control-cultures processed in 
parallel. Exposure to MeHg (10 - 25nM) resulted in a significant decrease in neuronal 
differentiation (Tuj1 quantification), similar to what was observed in rodent NSCs (Edoff 
et al. unpublished). 
 In conclusion, it appears that NSCs are promising in vitro models for 
neurotoxicity studies and that parameters such as cell proliferation, differentiation and 
migration are sensitive endpoints to identify substances with developmental neurotoxic 
potential. 
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 More than 200 chemicals have been reported to produce neurotoxicity in 
humans and some of them. are permanent organic pollutants and bioaccumulate in 
food chains, contaminating the food and, therefore, posing a risk for human health 
(Grandjean and Landrigan, 2006). This is the case, for example, with organochlorine 
pesticides, PCBs and methylmercury. Neurotoxicity is usually manifested as alterations 
of behavior including cognitive, motor and learning-memory processes, which are often 
a consequence of alterations in GABAergic and glutamatergic neurotransmission, and 
of neurodegenerative processes. Recent studies demonstrated the presence of 
environmental contaminants in human samples, including those from children. In fact, 
persistent organochlorine pesticides and methylmercury have been found with high 
frequency in placenta, cord blood and children’s adipose tissue (López-Espinosa et al., 
2007, 2008; Ramon et al., 2011; Younglai et al., 2002). Furthermore,  epidemiological 
studies found correlations between exposure to these neurotoxicants and neurological 
deficits in children (Grandjean and Landrigan, 2006; Morales et al., 2008; Freire et al., 
2010). Therefore, toxicity testing is needed for predicting neurotoxicity of low- and long-
term exposure to environmental pollutants. To this aim, we use primary neuronal 
cultures as experimental models for neurotoxicity testing.  
 Primary cultures of mouse cerebellar granule cells consist mainly of 
glutamatergic neurons (> 90 %) with a small proportion of GABAergic neurons (~ 6 %), 
whereas primary cultures of mouse cortical neurons contain both GABAergic, 
cholinergic and glutamatergic neurons as the main neuronal types (Solà et al., 2011; 
Sonnewald et al., 2004; Suñol et al., 2008). Moreover, the functional expression of 
GABA-A, glutamate, glycine and cholinergic receptors, as well as neuronal transporters 
for glutamate and GABA and enzymes for the synthesis/degradation of these 
neurotransmitters is well documented in the literature.  It has been reported that 
neurons develop in vitro faster than in vivo (Yu et al., 1984) acquiring characteristics of 
GABA and glutamate neurotransmisión within 1 – 2 weeks in culture (Yu et al., 1984; 
Frandsen and Schousboe, 1990; Griffiths et al., 1997; Hogberg et al., 2010). Therefore, 
cells can be exposed to chemicals either at maturation (after 1 week in vitro) or during 
their differentiation to study neurodevelopmental toxic effects/mechanisms of toxicity.  
We present here our recent findings on the prolonged effects of environmental 
persistent pollutants on GABA and glutamate neurotransmission, on redox 
homeostasis and on cytoskeletal proteins in primary rodent cultured neurons. 
 Dieldrin is one of the compounds included in the Stockholm Convention on 
Persistent Organic Pollutants because of its toxicity and high persistence in the 
environment. Exposure of primary cultures of cortical neurons to dieldrin for 6 days in 
vitro (div) resulted in cytotoxic effects at concentrations > 200 nM. Lower non-cytotoxic 
concentrations of dieldrin (e.g., 60 nM) significantly decreased GABAA receptor 
function as measured by the reduced binding of [35S]TBPS and reduced GABA-induced 
Cl- influx. This reduction of GABA neurotransmission is in agreement with the primary 
mechanisms of dieldrin neurotoxicity, namely the inhibition of the GABAA receptor. 
Accordingly, this in vitro inhibition will be predictive of an excitatory syndrome that 
eventually can lead to the induction of convulsions in mammals. However, this 
continuous inhibiton of the GABAA receptor might also induce a synaptic scaling 
compensatory effect, scaling down excitatory glutamate receptors to protect the CNS 
system from imbalance of excitatory-inhibitory neurotransmission (Watt et al., 2000). 
We found that prolonged in vitro exposure of cultured neurons to dieldrin resulted in 
decreased functionality of ionotropic NMDA and type I metabotropic mGluR5 glutamate 
receptors. This decreased activity was accounted for by internalization and down-
regulation of NMDA and mGluR5 receptors, respectively (Babot et al., 2005; Briz et al., 
2010). Figure 1 summarizes the effects of prolonged exposure to a non-toxic 
concentration of dieldrin on glutamatergic neurotransmission in primary cultures of 
cortical neurons. From these findings we conclude that prolonged exposure to dieldrin 
in vitro led to reduced performance of the GABAA and glutamate receptors, which may 
be predictive of deleterious consequences in vivo because NMDA receptor is involved 
in memory and learning processes. In fact, behavioral and learning deficits have been 
observed in monkeys chronically dosed with dieldrin (Smith et al., 1976). On the other 
hand, dieldrin has been reported to be an endocrine disruptor. In neurons, dieldrin 
inhibited [3H]estradiol binding to the neuronal estrogen receptor (ER) and induced the 
activation of the membrane ER downstream signaling pathways Akt and ERK. In 
addition, exposure to dieldrin for 6 div down-regulates the expression of neuronal 
ERalpha (Briz et al., 2011). These effects of dieldrin on ER levels and activation might 
contribute to cognitive and behavioral deficits (Schantz and Widholm, 2001). 
 
 Methylmercury is a neurotoxic agent to which the population is exposed through 
consumption of predator fishes that have bioaccumulated it (McDowell et al., 2004; 
Ramon et al., 2011). Targets of methylmercury in the CNS are the granule cell layer of 
the cerebellum and the cortex visual area. In cultured cerebellar granule cells, acute 
exposure to methylmercury inhibits neuronal glutamate uptake, increases extracellular 
glutamate, produces reactive oxygen species and increases intracellular calcium (Allen 
et al., 2001; Fonfría et al., 2005; Gassó et al., 2001).  Methylmercury-induced cell 
death was concentration- and time-dependent in cerebellar granule cells. Prolonged 
exposure of cerebellar granule cells during maturation in vitro to methylmercury 
resulted in reduced glutathione peroxydase (GPx) activity before methylmercury 
induced neuronal death, which was related to enhanced susceptibility to hydrogen-
peroxide. Accordingly, lipid peroxidation was produced, which was reversed by the 
antioxidant probucol. At the same time, probucol increased GPx activity. Likewise, 
overexpression of GPx-1 in cultured cerebellar granule cells resulted in neuroprotection 
against methylmercury-induced cell death (Farina et al., 2009). Figure 2 summarizes 
some of these findings. On the other hand, no effects were found in reduced and 
oxidized glutathione levels, glutathione reductase and catalase activity, nor on neuronal 
glutamate uptake or intracellular calcium, after using the same protocol for 
methylmercury exposure (Farina et al., 2009). Altogether, these results suggest that 
oxidative stress driven by inhibition of glutathione peroxidase may be one of the first 
hallmarks of methylmercury-induced neurotoxicity in the development of cerebellar 
granule cells, a finding also observed in mice exposed to methylmercury (Franco et al., 
2009). Under similar in vitro exposure conditions, an increase in non-phosphorylated 
cofilin and translocation of non-phosphorylated cofilin from the cytosol to the 
mitochondria was also found by means of a proteomic approach (Vendrell et al., 2010). 
The balance of cofilin phosphorylation / non-phosphorylation forms regulates actin 
dynamics and facilitates actin filament turnover, which are responsible for neuron 
shape change, migration, polarity formation and regulation of synaptic structures and 
function. Therefore, an alteration of the complex regulation of the cofilin 
phosphorylation/dephosphorylation pathway could be envisaged as an underlying 
mechanism compatible with reported signs of methylmercury-induced neurotoxicity 
such as those observed in vivo (apoptosis, cell migration deficits). 
.  
 In conclusion, cell-based methods using primary neuronal cultures of different 
cell types (cortical neurons and cerebellar granule neurons) constitute good models for 
testing the neurotoxicity of environmental pollutants. Non-cytotoxic concentrations of 
the agents have been used and this allowed us to determine their effects on neural 
functions in the absence of general toxicity. Following the recommendations of the US 
National Academies, I have shown that these models may be incorporated into a 
predictive strategy based on in vitro toxicity assays, because they are able to predict at 
a cellular level effects that can be extrapolated to effects on individuals.  
 
Conclusion. 
Toxicity prediction is particularly challenging in the case of chronic neurotoxicity 
and neurodevelopmental toxicity effects, and these areas place a particular challenge 
to the NRC 21st century vision strategy. In the symposium reported here, a comparison 
was presented on the current and proposed approaches to neurotoxicity testing, 
highlighting critical questions that need to be addressed and are of particular relevance 
in the transition from the present to the future approaches. While recognizing the 
difficulties ahead, this talk provided a hopeful view of significantly ameliorating our 
testing strategies for neurotoxicity prediction. An alternative view was presented at the 
symposium, defending that the goal of a complete in silico neurotoxicity prediction is 
possible in the very long term, but that approaching this goal will require the use of in 
vivo studies to collect large amounts of toxicity data for chemical epitopes. Within the 
predominant strategy of moving towards an increasing role for in vitro test systems, we 
need to know how subtle effects on brain function and development resulting from low 
dose or chronic exposure can be evaluated in these systems. The results discussed on 
this synopsis on neural stem cells and on long-term neuronal culture effects showed 
that in vitro systems can go beyond cytotoxicity assessment, and be useful in 
evaluating adverse functional effects likely relevant to chronic and developmental 
neurotoxicity. Evolving these contributions into practical tools for toxicity prediction is a 
challenging endeavor. 
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Legends 
Figure 1.- Effects of prolonged exposure to dieldrin on glutamatergic 
neurotransmission. Primary cultures of cortical neurons were continuously 
exposed to 60 nM dieldrin for 6 days in vitro (DIV) from the second day in vitro. 
Top panel: glutamate activity on both ionotropic (NMDA as agonist) and 
metabotropic (DHPG as group 1 mGluR agonist) receptors, as measured by the 
increase in intracellular calcium, was reduced by dieldrin. Bottom panel: dieldrin 
induced the internalization of NMDA receptor subunits and the down-regulation 
of the mGluR5, in agreement with the loss of function of NMDA and group-1 
metabotropic  glutamate receptors. Redrawn from Briz et al., 2010, with 
permission. 
Figure 2.- Effects of prolonged exposure to methylmercury (MeHg) on primary 
cultures of cerebellar granule cells. Top panel, left: Cultured cells were 
continuously exposed to methylmercury for 6 (■), 11 (▲) or 16 (▼) days in vitro 
(DIV) and cell viability was determined by means of the MTT assay. LC50 
values were in the range 200 – 500 nmol/L. Top panel, right: Cultured cells 
were continuously exposed to 300 nM methylmercury for 4 to 8 days in vitro. 
Methylmercury produced significant cell death after at least 5 days of in vitro 
exposure. Bottom panel: Glutathion peroxidase activity (left) and lipid 
peroxidation (right) in cells exposed to 300 nM methylmercury (MeHg) in the 
absence and in the presence of antioxidants (ascorbic acid, AA; trolox, TX; and 
probucol, PB) for 5 days in vitro. Redrawn from Farina et al., 2009 and Vendrell 
et al., 2010, with permission. 
 
 Table 1.  Regulatory test guidelines with evaluations of the nervous system 
Guideline Life-stage Exposure Period 
EPA 
OPPTS OECD 
Standard toxicity tests Adult 28-day, 90-day, or 
chronic 
870.3050 
870.3100 
870.4100 
407 
408 
452 
Delayed neurotoxicity of 
organophosphorous 
substances 
Adult Acute and 28-day 870.6100 418,419 
Neurotoxicity screening 
battery 
Adult Acute and 90-day 870.6200 424 
Developmental neurotoxicity Developmental GD6-PND21 870.6300 426 
Schedule-controlled operant 
behavior 
Adult  870.6500 None 
Peripheral nerve function Adult  870.6850 None 
Neurophysiology:  Sensory 
evoked potentials 
Adult  870.6855 None 
Extended 1-generation Developmental 2 weeks prior to 
mating, throughout 
mating, gestation, 
and lactation until 
F1 are adults 
None Draft 
 
Table 1
Table 2.  Specific clinical, behavioral, and pathology evaluations in guideline studies 
Endpoint Standard Toxicity Adult Neurotoxicity 
Developmental 
Neurotoxicity 
Extended 1-
Generation 
Detailed clinical 
observations in an open 
field 
Weekly, not blind Weekly, not blind Dams:  2x during 
gestation; 2x during 
lactation; blind 
F1 offspring:  PND 4, 11, 
21, 35, 45, and 60; blind 
Weekly, not blind 
Functional tests 
(neuromuscular and 
reactivity to sensory 
stimuli) 
1x (last week of 
exposure) 
Recommended as 
part of FOB below 
Not required Recommended as 
part of FOB below 
Motor activity, automated 1x (last week of 
exposure) 
4x:  Pretest and 3x PND 13, 17, 21, 60 1x PND 63-75 
Functional observational 
battery (FOB) 
Not required 4x:  Pretest and 3x, 
blind 
Not required 1x PND 63-75, blind 
Neuropathology Immersion fixation:  
brain, spinal cord 
Perfusion fixation: 
brain, spinal cord, 
and ganglia, 
peripheral nerve 
PND 11 or 22 brain; PND 
60 same as for adults; 
brain morphometry 
1x PND 75-90; same 
as for PND 60 DNT 
including brain 
morphometry 
Auditory startle habituation Not required Not required 2x (weaning and adult) 1x PND 24 
Learning and memory 
 
Not required Not required 2x (weaning and adult) Not required 
Table 2
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